Found: 103
Select item for more details and to access through your institution.
Structural Aspects of Receptor Dimerization.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 766, n. 1, p. 344, doi. 10.1111/j.1749-6632.1995.tb26685.x
- By:
- Publication type:
- Article
Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 226, doi. 10.1007/s002620000112
- By:
- Publication type:
- Article
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
- Published in:
- Oncogene, 2001, v. 20, n. 2, p. 147, doi. 10.1038/sj.onc.1204062
- By:
- Publication type:
- Article
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer.
- Published in:
- Oncogene, 2000, v. 19, n. 53, p. 6102, doi. 10.1038/sj.onc.1203973
- By:
- Publication type:
- Article
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
- Published in:
- Oncogene, 1998, v. 16, n. 10, p. 1249, doi. 10.1038/sj.onc.1201642
- By:
- Publication type:
- Article
Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation.
- Published in:
- Oncogene, 1997, v. 15, n. 23, p. 2803, doi. 10.1038/sj.onc.1201466
- By:
- Publication type:
- Article
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.
- Published in:
- 2016
- By:
- Publication type:
- journal article
ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 2, p. 269, doi. 10.1002/ijc.21818
- By:
- Publication type:
- Article
CircRNAs: role in human diseases and potential use as biomarkers.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 5, p. 1, doi. 10.1038/s41419-021-03743-3
- By:
- Publication type:
- Article
Irreversible modifications of receptor tyrosine kinases.
- Published in:
- FEBS Letters, 2018, v. 592, n. 13, p. 2199, doi. 10.1002/1873-3468.13095
- By:
- Publication type:
- Article
Tumor suppressor microRNAs: A novel non-coding alliance against cancer.
- Published in:
- FEBS Letters, 2014, v. 588, n. 16, p. 2639, doi. 10.1016/j.febslet.2014.03.033
- By:
- Publication type:
- Article
Steering tumor progression through the transcriptional response to growth factors and stroma.
- Published in:
- FEBS Letters, 2014, v. 588, n. 15, p. 2407, doi. 10.1016/j.febslet.2014.05.036
- By:
- Publication type:
- Article
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.
- Published in:
- FASEB Journal, 2012, v. 26, n. 4, p. 1582, doi. 10.1096/fj.11-194654
- By:
- Publication type:
- Article
Kinase‐mediated quasi‐dimers of EGFR.
- Published in:
- FASEB Journal, 2010, v. 24, n. 12, p. 4744, doi. 10.1096/fj.10.166199
- By:
- Publication type:
- Article
Kinase-mediated quasi-dimers of EGFR.
- Published in:
- FASEB Journal, 2010, v. 24, n. 12, p. 4744, doi. 10.1096/fj.10-166199
- By:
- Publication type:
- Article
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy.
- Published in:
- Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01200-x
- By:
- Publication type:
- Article
Molecular ticket to enter cells.
- Published in:
- Nature, 2002, v. 416, n. 6877, p. 133, doi. 10.1038/416133a
- By:
- Publication type:
- Article
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.
- Published in:
- Nature Communications, 2014, v. 5, n. 10, p. 5073, doi. 10.1038/ncomms6073
- By:
- Publication type:
- Article
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis.
- Published in:
- Science Signaling, 2021, v. 14, n. 688, p. 1, doi. 10.1126/scisignal.abe6156
- By:
- Publication type:
- Article
Roles for growth factors and mutations in metastatic dissemination.
- Published in:
- Biochemical Society Transactions, 2021, v. 49, n. 3, p. 1409, doi. 10.1042/BST20210048
- By:
- Publication type:
- Article
The short and the long: non-coding RNAs and growth factors in cancer progression.
- Published in:
- Biochemical Society Transactions, 2017, v. 45, n. 1, p. 51, doi. 10.1042/BST20160131
- By:
- Publication type:
- Article
The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.
- Published in:
- EMBO Journal, 1999, v. 18, n. 12, p. 3348, doi. 10.1093/emboj/18.12.3348
- By:
- Publication type:
- Article
Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.
- Published in:
- EMBO Journal, 1998, v. 17, n. 20, p. 5948, doi. 10.1093/emboj/17.20.5948
- By:
- Publication type:
- Article
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.
- Published in:
- EMBO Journal, 1998, v. 17, n. 12, p. 3385, doi. 10.1093/emboj/17.12.3385
- By:
- Publication type:
- Article
Bivalence of EGF-like ligands drives the ErbB signaling network.
- Published in:
- EMBO Journal, 1997, v. 16, n. 16, p. 4938, doi. 10.1093/emboj/16.16.4938
- By:
- Publication type:
- Article
The heregulin gene can be included in the 8p12 amplification unit in human breast cancer.
- Published in:
- Genes, Chromosomes & Cancer, 1994, v. 11, n. 1, p. 66, doi. 10.1002/gcc.2870110111
- By:
- Publication type:
- Article
The key roles of cancer stem cell-derived extracellular vesicles.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00499-2
- By:
- Publication type:
- Article
Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases.
- Published in:
- Oncogene, 2004, v. 23, n. 11, p. 2057, doi. 10.1038/sj.onc.1207390
- By:
- Publication type:
- Article
c-Cbl is a critical modulator of the Ron tyrosine kinase receptor.
- Published in:
- Oncogene, 2003, v. 22, n. 24, p. 3669, doi. 10.1038/sj.onc.1206585
- By:
- Publication type:
- Article
Neu and its ligands: From an oncogene to neural factors.
- Published in:
- BioEssays, 1993, v. 15, n. 12, p. 815, doi. 10.1002/bies.950151207
- By:
- Publication type:
- Article
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 4, p. 1, doi. 10.15252/emmm.202013144
- By:
- Publication type:
- Article
An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 2, p. 294, doi. 10.15252/emmm.201708076
- By:
- Publication type:
- Article
LIMT is a novel metastasis inhibiting lnc RNA suppressed by EGF and downregulated in aggressive breast cancer.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 9, p. 1052, doi. 10.15252/emmm.201606198
- By:
- Publication type:
- Article
5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02380-8
- By:
- Publication type:
- Article
A module of negative feedback regulators defines growth factor signaling.
- Published in:
- Nature Genetics, 2007, v. 39, n. 4, p. 503, doi. 10.1038/ng1987
- By:
- Publication type:
- Article
Methyl-CpG binding domain 2 (Mbd2) is an epigenetic regulator of autism-risk genes and cognition.
- Published in:
- Translational Psychiatry, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41398-023-02561-9
- By:
- Publication type:
- Article
Enlightened receptor dynamics.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 2, p. 169, doi. 10.1038/nbt0204-169
- By:
- Publication type:
- Article
TAZ facilitates breast tumor growth by promoting an immune‐suppressive tumor microenvironment.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2675, doi. 10.1002/1878-0261.13525
- By:
- Publication type:
- Article
Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 11, p. 2415, doi. 10.1002/1878-0261.13473
- By:
- Publication type:
- Article
The circRNA–microRNA code: emerging implications for cancer diagnosis and treatment.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 4, p. 669, doi. 10.1002/1878-0261.12468
- By:
- Publication type:
- Article
Cancer therapeutic antibodies come of age: Targeting minimal residual disease
- Published in:
- Molecular Oncology, 2007, v. 1, n. 1, p. 42, doi. 10.1016/j.molonc.2007.01.003
- By:
- Publication type:
- Article
The ErbB/HER family of receptor tyrosine kinases: A potential target for chemoprevention of epithelial neoplasms.
- Published in:
- Journal of Cellular Biochemistry, 2000, v. 77, p. 52, doi. 10.1002/(SICI)1097-4644(2000)77:34+<52::AID-JCB10>3.0.CO;2-X
- By:
- Publication type:
- Article
Feedback regulation of EGFR signalling: decision making by early and delayed loops.
- Published in:
- Nature Reviews Molecular Cell Biology, 2011, v. 12, n. 2, p. 104, doi. 10.1038/nrm3048
- By:
- Publication type:
- Article
EGF–ERBB signalling: towards the systems level.
- Published in:
- Nature Reviews Molecular Cell Biology, 2006, v. 7, n. 7, p. 505, doi. 10.1038/nrm1962
- By:
- Publication type:
- Article
UNTANGLING THE ErbB SIGNALLING NETWORK.
- Published in:
- Nature Reviews Molecular Cell Biology, 2001, v. 2, n. 2, p. 127, doi. 10.1038/35052073
- By:
- Publication type:
- Article
The Biological Framework: Translational Research from Bench to Clinic.
- Published in:
- Oncologist, 2011, v. 16, p. 23, doi. 10.1634/theoncologist.2011-S1-23
- By:
- Publication type:
- Article
The Biological Framework: Translational Research from Bench to Clinic.
- Published in:
- Oncologist, 2011, v. 16, p. 23, doi. 10.1634/theoncologist.2011-S1-23
- By:
- Publication type:
- Article
The Biological Framework: Translational Research from Bench to Clinic.
- Published in:
- Oncologist, 2010, v. 15, p. 1, doi. 10.1634/theoncologist.2010-S5-01
- By:
- Publication type:
- Article
Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.951267
- By:
- Publication type:
- Article
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 11, p. 1214, doi. 10.1002/emmm.201201483
- By:
- Publication type:
- Article